Orchestra BioMed (OBIO) Competitors $2.60 +0.03 (+1.17%) Closing price 04:00 PM EasternExtended Trading$2.60 0.00 (-0.19%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OBIO vs. DCTH, BFLY, RXST, CARL, NPCE, DRTS, CLPT, SNWV, SMTI, and TCMDShould you be buying Orchestra BioMed stock or one of its competitors? The main competitors of Orchestra BioMed include Delcath Systems (DCTH), Butterfly Network (BFLY), RxSight (RXST), Carlsmed (CARL), NeuroPace (NPCE), Alpha Tau Medical (DRTS), ClearPoint Neuro (CLPT), Sanuwave Health (SNWV), Sanara MedTech (SMTI), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Orchestra BioMed vs. Its Competitors Delcath Systems Butterfly Network RxSight Carlsmed NeuroPace Alpha Tau Medical ClearPoint Neuro Sanuwave Health Sanara MedTech Tactile Systems Technology Delcath Systems (NASDAQ:DCTH) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Do analysts recommend DCTH or OBIO? Delcath Systems presently has a consensus price target of $24.50, indicating a potential upside of 129.62%. Orchestra BioMed has a consensus price target of $13.50, indicating a potential upside of 419.23%. Given Orchestra BioMed's higher possible upside, analysts clearly believe Orchestra BioMed is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Orchestra BioMed 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in DCTH or OBIO? 61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 53.2% of Orchestra BioMed shares are owned by institutional investors. 17.9% of Delcath Systems shares are owned by insiders. Comparatively, 8.1% of Orchestra BioMed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is DCTH or OBIO more profitable? Delcath Systems has a net margin of 3.18% compared to Orchestra BioMed's net margin of -2,367.49%. Delcath Systems' return on equity of 6.91% beat Orchestra BioMed's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems3.18% 6.91% 5.80% Orchestra BioMed -2,367.49%-289.42%-110.04% Does the media favor DCTH or OBIO? In the previous week, Orchestra BioMed had 2 more articles in the media than Delcath Systems. MarketBeat recorded 4 mentions for Orchestra BioMed and 2 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.84 beat Orchestra BioMed's score of 0.70 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Orchestra BioMed 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, DCTH or OBIO? Delcath Systems has higher revenue and earnings than Orchestra BioMed. Orchestra BioMed is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M10.03-$26.39M$0.05213.40Orchestra BioMed$2.64M38.05-$61.02M-$1.83-1.42 Which has more risk & volatility, DCTH or OBIO? Delcath Systems has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Orchestra BioMed has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. SummaryDelcath Systems beats Orchestra BioMed on 12 of the 16 factors compared between the two stocks. Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBIO vs. The Competition Export to ExcelMetricOrchestra BioMedMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.31M$3.15B$5.78B$10.19BDividend YieldN/A2.33%5.73%4.61%P/E Ratio-1.4221.2474.8626.40Price / Sales38.05456.43540.53124.73Price / CashN/A44.4425.8129.91Price / Book2.999.6413.256.28Net Income-$61.02M-$53.20M$3.29B$270.38M7 Day Performance-4.76%0.44%0.47%2.70%1 Month Performance1.17%4.26%4.60%5.99%1 Year Performance-55.33%9.43%73.42%25.94% Orchestra BioMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOOrchestra BioMed2.9246 of 5 stars$2.60+1.2%$13.50+419.2%-55.8%$99.31M$2.64M-1.424Short Interest ↑DCTHDelcath Systems3.0622 of 5 stars$11.44-1.0%$24.50+114.3%+13.6%$400.21M$37.21M228.8260Positive NewsBFLYButterfly Network3.1864 of 5 stars$1.58-0.9%$3.00+90.5%-18.5%$396.49M$82.06M-5.63460RXSTRxSight1.9217 of 5 stars$9.50+6.3%$10.00+5.3%-83.1%$390.01M$139.93M-11.91220Trending NewsCARLCarlsmedN/A$13.21-1.3%N/AN/A$351.12MN/A0.00100Negative NewsNPCENeuroPace3.1841 of 5 stars$9.97+2.6%$16.60+66.6%+32.7%$329.15M$79.91M-11.85170Positive NewsDRTSAlpha Tau Medical2.2353 of 5 stars$3.76+1.9%$9.00+139.4%+62.8%$318.84MN/A-7.8380Negative NewsCLPTClearPoint Neuro2.0698 of 5 stars$11.04+1.0%$19.67+78.2%-16.7%$314.15M$31.39M-13.64110News CoverageAnalyst UpgradeSNWVSanuwave Health2.0394 of 5 stars$36.54+1.7%$55.00+50.5%N/A$313.15M$32.63M-4.4340SMTISanara MedTech2.3351 of 5 stars$35.18-1.6%$50.00+42.1%-1.5%$310.70M$86.67M-30.0960Analyst UpgradeTCMDTactile Systems Technology2.4188 of 5 stars$13.61+1.2%$13.50-0.8%-2.5%$303.37M$292.98M21.951,037Positive News Related Companies and Tools Related Companies DCTH Competitors BFLY Competitors RXST Competitors CARL Competitors NPCE Competitors DRTS Competitors CLPT Competitors SNWV Competitors SMTI Competitors TCMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OBIO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBIO Stock Alerts